| 臺大學術典藏 |
2022-04-26T07:50:29Z |
Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer
|
Chen J.L.-Y.; Pan C.-K.; Lin Y.-L.; Tsai C.-Y.; Huang Y.-S.; WEN-CHI YANG; Hsu F.-M.; Kuo S.-H.; Shieh M.-J. |
| 臺大學術典藏 |
2022-04-26T07:50:29Z |
Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)
|
WEN-CHI YANG; Chen Y.-F.; Yang C.-C.; Wu P.-F.; Chan H.-M.; Chen J.L.-Y.; Chen G.-Y.; Cheng J.C.-H.; Kuo S.-H.; Hsu F.-M. |
| 臺大學術典藏 |
2022-04-25T07:36:16Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; Chou W.-C.; JIA-HAU LIU; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2022-04-25T07:36:11Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; JIA-HAU LIU; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-04-14T07:20:22Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; FENG-MING TIEN; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-03-25T02:05:46Z |
Medulloblastoma in adults: Treatment outcome, relapse patterns, and prognostic factors
|
SHIH-FAN LAI; Wang C.-W.; Chen Y.-H.; Lan K.-H.; Cheng J.C.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-25T02:05:45Z |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1�V2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
SHIH-FAN LAI; Chen Y.-H.; Kuo W.-H.; Lien H.-C.; Wang M.-Y.; Lu Y.-S.; Lo C.; Kuo S.-H.; Cheng A.-L.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-25T02:05:45Z |
Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasion
|
Liang T.H.-K.; Kuo S.-H.; Wang C.-W.; Chen W.-Y.; Hsu C.-Y.; SHIH-FAN LAI; Tseng H.-M.; You S.-L.; Chen C.-M.; Tseng W.-Y.I. |
| 臺大學術典藏 |
2022-03-25T02:05:44Z |
The extent of edema and tumor synchronous invasion into the subventricular zone and corpus callosum classify outcomes and radiotherapy strategies of glioblastomas
|
Liang H.-K.T.; Chen W.-Y.; SHIH-FAN LAI; Su M.-Y.; You S.-L.; Chen L.-H.; Tseng H.-M.; Chen C.-M.; Kuo S.-H.; Tseng W.-Y.I. |
| 臺大學術典藏 |
2022-03-25T02:05:43Z |
The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation
|
SHIH-FAN LAI; Chen Y.-H.; Liang T.H.-K.; Hsu C.-Y.; Lien H.-C.; Lu Y.-S.; Huang C.-S.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-25T02:05:42Z |
Whether adjuvant radiotherapy is desired for postmastectomy patients with T1�VT2 tumors and 1�V3 positive axillary lymph nodes who received modern systemic therapy?
|
SHIH-FAN LAI; Huang C.-S.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-15T05:39:28Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; WEI-WU CHEN; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
PO-HAN LIN; Kuo W.-H.; Huang A.-C.; Lu Y.-S.; Lin C.-H.; Kuo S.-H.; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; Chen P.-L.; Ni Y.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:37Z |
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer
|
Kuo S.-H.; Yang S.-Y.; You S.-L.; Lien H.-C.; Lin C.-H.; PO-HAN LIN; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer
|
PO-HAN LIN; Chen M.; Tsai L.-W.; Lo C.; Yen T.-C.; Huang T.Y.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
PO-HAN LIN; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-08T03:44:08Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:08Z |
Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma [2]
|
SHIH-HUNG YANG; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:07Z |
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
|
SHIH-HUNG YANG; Lin L.-W.; Fang Y.-J.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:07Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:06Z |
Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-�eb is associated with a poor prognosis of pancreatic cancer
|
SHIH-HUNG YANG; Hsu C.-H.; Lee J.-C.; Tien Y.-W.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:05Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:04Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:04Z |
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer
|
SHIH-HUNG YANG; Guo J.-C.; Yeh K.-H.; Tien Y.-W.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:03Z |
Postoperative imaging and tumor marker surveillance in resected pancreatic cancer
|
Wu H.; Guo J.-C.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:03Z |
A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma
|
SHIH-HUNG YANG; Shao Y.-Y.; Lin C.-C.; Kuo S.-H.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
S-1�Vassociated hypertriglyceridemia in a patient with pancreatic adenocarcinoma
|
Chen H.-W.; Kuo H.-Y.; Chen B.-B.; Tien Y.-W.; Kuo S.-H.; SHIH-HUNG YANG |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
SHIH-HUNG YANG; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
SHIH-HUNG YANG; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:43:59Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
Kuo S.-H.; SHIH-HUNG YANG; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:43:58Z |
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
|
Chen Y.-L.; Tsai C.-L.; Cheng J.C.-H.; Wang C.-W.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-04T05:33:29Z |
Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer
|
Chen W.-Y.; CHEN-TU WU; Wang C.-W.; Lan K.-H.; Liang H.-K.; Huang B.-S.; Chang Y.-L.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-22T03:37:23Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-21T03:52:43Z |
Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical application
|
JIH-HSIANG LEE; Cheng A.-L.; Lin C.-W.; Kuo S.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:38Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H.; Shen C.-Y.; JIH-HSIANG LEE; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-21T02:04:31Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
Kuo S.-H.; Yang S.-H.; Wei M.-F.; Lee H.-W.; Tien Y.-W.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2022-02-18T08:46:57Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEN-CHUAN CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-18T08:46:49Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; Liou J.-M.; Chen M.-J.; CHIEN-CHUAN CHEN; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:26:08Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEH-CHANG CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-18T08:26:07Z |
Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis
|
Han M.-L.; CHIEH-CHANG CHEN; Kuo S.-H.; Hsu W.-F.; Liou J.-M.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T06:29:01Z |
Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis
|
Han M.-L.; Chen C.-C.; Kuo S.-H.; WEN-FENG HSU; Liou J.-M.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
|
Yang S.-H.; Lin L.-W.; YU-JEN FANG; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; YU-JEN FANG; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-01-25T02:29:53Z |
Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application
|
LEE JIH-HSIANG; Cheng, A-L; Lin, C-W; Kuo, S-H |
| 臺大學術典藏 |
2022-01-14T03:59:35Z |
Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase?1 inhibition [Strahlenempfindlichkeit beim ?sophagealen Plattenepithelkarzinom: Wirksamkeit des Polo-like-Kinase-1-Inhibitors]
|
Chen J.L.-Y.; JO-PAI CHEN; Huang Y.-S.; Tsai Y.-C.; Tsai M.-H.; Jaw F.-S.; Cheng J.C.-H.; Kuo S.-H.; Shieh M.-J. |
| 臺大學術典藏 |
2022-01-14T03:59:35Z |
Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective study
|
Chen J.L.-Y.; Shen C.-W.; Wang C.-C.; Huang Y.-S.; JO-PAI CHEN; Chiang C.-H.; Lin Y.-L.; Kuo S.-H.; Wang C.-W. |
| 臺大學術典藏 |
2022-01-14T03:59:34Z |
Efficacy of a programmed death-1 checkpoint inhibitor in a case of cutaneous squamous cell carcinoma harboring mutations of TP53 and BRCA2
|
Ma W.-L.; Chou C.-H.; JO-PAI CHEN; Kuo S.-H. |
| 臺大學術典藏 |
2022-01-12T07:07:24Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; HSIN-AN HOU; Chou W.-C.; Liu J.-H.; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2022-01-12T07:07:09Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; HSIN-AN HOU; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-01-10T05:34:05Z |
Lysophosphatidic acid alters the expression profiles of angiogenic factors, cytokines, and chemokines in mouse liver sinusoidal endothelial cells
|
Chou C.-H.; SHUO-LUN LAI; Ho C.-M.; Lin W.-H.; Chen C.-N.; Lee P.-H.; Peng F.-C.; Kuo S.-H.; Wu S.-Y.; Lai H.-S. |
